Chronic kidney disease trials in Mexico

In Mexico 22 Also abroad 798

22 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Chihuahua City, Cuauhtémoc, D.F, Durango, Guadalajara, Mazatlán, Mérida, San Luis Potosí City, Veracruz, Zapopan
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Actopan, Ciudad Madero, Cuernavaca, Culiacán, Durango, Guadalajara, Hermosillo, León, Mérida, Mexicali, México, Mexico City, Monterrey, Tijuana, Veracruz, Villahermosa
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Veracruz
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
No phaseTaking people
Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis
Where
Mexico City
Age
40 years to 70 years
People
110
Run by
Coordinación de Investigación en Salud, Mexico
See details and how to joinNCT06069518
No phaseNot yet taking people in Mexico
A Study to Learn More About How Well Finerenone Works in Real-world in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social)
Where
Multiple Locations
Age
18 years and over
People
800
Run by
Bayer
See details and how to joinNCT07841015
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Benito Juárez, Querétaro
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Aguascalientes, México D.F., México, D.F., Monterrey, Veracruz
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Benito Juárez, Culiacán, Durango, Ecatepec de Morelos, Estado de México, México, Mexico City, Tuxpan, Veracruz, Villahermosa, Xalapa
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Mexico City, Monterrey
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
No phaseTaking people
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Where
Iztapalapa, León, México, Mexico City
Age
18 years and over
People
35,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT03549754
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Chihuahua City, Culiacán, Mazatlán, Mérida, Monterrey, Zapopan
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Chihuahua City, Cuernavaca, Guadalajara, Mexico City, Monterrey, Zapopan
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
No phaseTaking people
The FILTRATE Trial: High-Rate Ultrafiltration for Intravascular Congestion
Where
Monterrey
Age
18 years and over
People
70
Run by
Universidad Autonoma de Nuevo Leon
See details and how to joinNCT07705269
No phaseTaking people
Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients
Where
Monterrey
Age
18 years and over
People
60
Run by
Hospital Universitario Dr. Jose E. Gonzalez
See details and how to joinNCT07694791
Phase 1/2Taking people
Intradialytic Exercise Combined With Creatine Monohydrate in Patients With Chronic Kidney Disease Undergoing Hemodialysis.
Where
Colima
Age
18 years and over
People
48
Run by
Pedro Julian Flores Moreno
See details and how to joinNCT07666815
Phase 4Taking people
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease
Where
Aguascalientes
Age
14 years to 18 years
People
200
Run by
Centenario Hospital Miguel Hidalgo
See details and how to joinNCT07405216
Phase 3Taking people
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Where
Cuernavaca, Guadalajara, Mexico City
Age
2 years to 17 years
People
129 worldwide
Run by
AMAG Pharmaceuticals, Inc.
See details and how to joinNCT03619850 · EU 2024-516263-92-00
No phaseNot yet taking people in Mexico
Multimodal Intervention for Early Chronic Kidney Disease in Young People: Dysbiosis and Inflammation (CKD)
Where
Aguascalientes
Age
14 years to 35 years
People
200
Run by
Centenario Hospital Miguel Hidalgo
See details and how to joinNCT07483697
Phase 4Not yet taking people in Mexico
Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)
Where
Guadalajara
Age
18 years and over
People
54
Run by
Hospital Civil de Guadalajara
See details and how to joinNCT07404345
No phaseEnrolling by invitation
Type 2 Diabetes and Associated Factors in Mexico
Where
Mexico City
Age
18 years and over
People
1,000
Run by
Coordinación de Investigación en Salud, Mexico
See details and how to joinNCT07248891
No phaseEnrolling by invitation
Intradialysis Exercise Functional Capacity, Body Composition and Survival in Hemodialysis Patients
Where
León
Age
18 years to 50 years
People
50
Run by
Universidad de Guanajuato
See details and how to joinNCT06788054
No phaseTaking people
Effect of a Specialized Oral Supplement on Nutritional Status and Quality of Life in Non-dialysis CKD
Where
Guadalajara
Age
18 years to 90 years
People
50
Run by
NIN Institute
See details and how to joinNCT06576479